SpectraGenetics
Pittsburgh · Founded 2012
About SpectraGenetics
SpectraGenetics is a GPCR Company with proprietary technology for the direct measurement of GPCR internalization, trafficking and recylcling back to the cell membrane. This technology does not rely on secondary messengers or require imaging. It is based on Fluorogen Activating Peptide (FAP) technology originally developed at Carnegie Mellon University. The company has tagged more than 150 GPCRs and has validated more than 30 cell lines.
Company Facts
- Founded: 2012
- Legal name: SpectraGenetics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $52.0K
- Last round: Convertible Note (Nov 2010)
- Website: spectragenetics.com
- Phone: +1 412-488-9350
Social Profiles
Canonical: https://fsome.com/organization/spectragenetics-8316677 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.